AAAAAA
Results:
1-13
|
Results: 13
Authors:
PRALORAN V
COMTE L
LEMEUR Y
ALDIGIER JC
Citation: V. Praloran et al., REGULATION OF ERYTHROPOIESIS BY BONE-MARROW RENINANGIOTENSIN SYSTEM -FACTS AND SPECULATIONS, Experimental hematology, 26(11), 1998, pp. 1020-1021
Authors:
LEMEUR Y
ALDIGIER JC
PRALORAN V
Citation: Y. Lemeur et al., IS PLASMA AC-SDKP LEVEL A RELIABLE MARKER OF CHRONIC ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN HYPERTENSIVE PATIENTS, Hypertension, 31(5), 1998, pp. 1201-1201
Authors:
LEMEUR Y
PARAF F
SZELAG JC
ALDIGIER JC
LEROUXROBERT C
Citation: Y. Lemeur et al., ACUTE-RENAL-FAILURE IN A MARATHON RUNNER - ROLE OF GLOMERULAR BLEEDING IN TUBULAR INJURY, The American journal of medicine, 105(3), 1998, pp. 251-252
Authors:
RUILOPE LM
ALDIGIER JC
PONTICELLI C
ODDOUSTOCK P
BOTTERI F
MANN JF
Citation: Lm. Ruilope et al., SAFETY OF THE COMBINATION OF VALSARTAN (V) AND BENAZEPRIL (BZ) IN PATIENTS WITH CHRONIC RENAL-DISEASE (CRD), Journal of the American Society of Nephrology, 8, 1997, pp. 361-361
Authors:
CORNU E
LACROIX P
VIROT P
ALDIGIER JC
PRALORAN P
CHRISTIDES C
LASKAR M
Citation: E. Cornu et al., M-CSF SEROUS RATE EVOLUTION DURING POSTTRANSPLANTATION DAYS IN A HETEROTOPIC HEART GRAFT MODEL MICE, Journal of Cardiovascular Surgery, 38(6), 1997, pp. 567-570
Authors:
COMTE L
LORGEOT V
VOLKOV L
ALLEGRAUD A
ALDIGIER JC
PRALORAN V
Citation: L. Comte et al., EFFECTS OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ENALAPRIL ON BLOOD HEMATOPOIETIC PROGENITORS AND ACETYL-N-SER-ASP-LYS-PRO CONCENTRATIONS, European journal of clinical investigation, 27(9), 1997, pp. 788-790
Authors:
DENIZOT Y
ROUGIER F
DUPUIS F
VERGER C
DULERY C
LASKAR M
ALDIGIER JC
PRALORAN V
Citation: Y. Denizot et al., PAF AND HEMATOPOIESIS .8. BIOSYNTHESIS AND METABOLISM OF PAF BY HUMANBONE-MARROW STROMAL CELLS, Experimental hematology, 24(11), 1996, pp. 1327-1332
Authors:
POUX JM
BOUDET R
LACROIX P
JAUBERTEAU MO
PLOUIN PF
ALDIGIER JC
LEROUXROBERT C
Citation: Jm. Poux et al., RENAL INFARCTION AND THROMBOSIS OF THE INFRARENAL AORTA IN A 35-YEAR-OLD MAN WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME, American journal of kidney diseases, 27(5), 1996, pp. 721-725
Authors:
LEMEUR Y
FIXE P
ALDIGIER JC
LEROUXROBERT C
PRALORAN V
Citation: Y. Lemeur et al., MACROPHAGE-COLONY-STIMULATING FACTOR INVOLVEMENT IN UREMIC PATIENTS, Kidney international, 50(3), 1996, pp. 1007-1012
Authors:
LEMEUR Y
MOESCH C
RINCE M
ALDIGIER JC
LEROUXROBERT C
Citation: Y. Lemeur et al., POTENTIAL NEPHROTOXICITY OF INTRAVENOUS INFUSIONS OF NAFTIDROFURYL OXALATE, Nephrology, dialysis, transplantation, 10(9), 1995, pp. 1751-1755
Authors:
ROLLE F
ROGER D
BEDANE C
ALDIGIER JC
SERHAL C
BONNETBLANC JM
LASKAR M
Citation: F. Rolle et al., EHLERS-DANLOS TYPE-IV SYNDROME WITH ACROG ERIA REVEALED BY RENOVASCULAR HYPERTENSION, Journal des maladies vasculaires, 19(4), 1994, pp. 323-325
Authors:
ROUAN MC
LECAILLON JB
GODBILLON J
MENARD F
DARRAGON T
MEYER P
KOURILSKY O
HILLION D
ALDIGIER JC
JUNGERS P
Citation: Mc. Rouan et al., THE EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF OXCARBAZEPINE AND ITS METABOLITES, European Journal of Clinical Pharmacology, 47(2), 1994, pp. 161-167
Authors:
ROGER D
ALDIGIER JC
PEYRONNET P
BONNETBLANC JM
LEROUXROBERT C
Citation: D. Roger et al., ACQUIRED ICHTHYOSIS AND PYODERMA-GANGRENOSUM IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Clinical and experimental dermatology, 18(3), 1993, pp. 268-270
Risultati:
1-13
|